D. Medical Rises Most in Two Weeks on Potential Acquisition

D. Medical Industries Ltd. (DMED) rose the most in almost two weeks after the maker of drug delivery devices said it is negotiating a potential acquisition of a diabetes devices company.

The shares surged 7.9 percent, the most since June 7, to 1.605 shekels, at 4:05 p.m. in Tel Aviv, lifting the company’s market value to 17.4 million shekels ($4.5 million).

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.